Edition:
United States

Argos Therapeutics Inc (ARGS.OQ)

ARGS.OQ on NASDAQ Stock Exchange Capital Market

0.29USD
4:00pm EDT
Change (% chg)

$-0.04 (-12.90%)
Prev Close
$0.33
Open
$0.34
Day's High
$0.36
Day's Low
$0.27
Volume
849,926
Avg. Vol
140,110
52-wk High
$11.95
52-wk Low
$0.27

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 1.67 -8.614
Sep '17 0.05 -2.083
Jun '17 0.07 -4.127
Mar '17 0.11 -11.657
FY 2016 Dec '16 0.16 -4.582
Sep '16 0.15 -11.830
Jun '16 0.49 -9.672
Mar '16 0.15 -11.342
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.05 0.05 0.05 --
Quarter Ending Sep-18 1 0.05 0.05 0.05 --
Year Ending Dec-18 1 0.20 0.20 0.20 9.90
Earnings (per share)
Quarter Ending Jun-18 1 -1.80 -1.80 -1.80 --
Quarter Ending Sep-18 1 -1.80 -1.80 -1.80 --
Year Ending Dec-18 1 -7.00 -7.00 -7.00 -15.93
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.65 33.25
P/E High - Last 5 Yrs. -- 40.51 45.98
P/E Low - Last 5 Yrs. -- 24.06 24.86
Beta 1.32 0.81 0.80
Price to Sales (TTM) 2.54 4.62 7.20
Price to Book (MRQ) -- 4.03 5.06
Price to Tangible Book (MRQ) -- 4.93 6.69
Price to Cash Flow (TTM) -- 22.24 25.20
% Owned Institutions 6.56 1.18 2.26

Dividends

  Company industry sector
Dividend Yield -- 1.62 1.53
Dividend Yield - 5 Year Avg -- 0.74 0.76
Dividend 5 Year Growth Rate -- 2.75 3.96
Payout Ratio(TTM) -- 20.50 20.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 921.11 6.93 8.73
Sales (TTM) vs TTM 1 Yr. Ago 100.89 9.93 11.30
Sales - 5 Yr. Growth Rate -23.05 7.66 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -88.00 19.48 22.52
EPS (TTM) vs TTM 1 Yr. Ago 29.24 -- --
EPS - 5 Yr. Growth Rate -- 8.96 10.26
Capital Spending - 5 Yr. Growth Rate 26.43 9.68 10.40

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.52 2.53
Current Ratio (MRQ) 1.80 3.60 3.61
LT Debt to Equity (MRQ) -- 8.83 11.52
Total Debt to Equity (MRQ) -- 11.17 14.21
Interest Coverage (TTM) -72.62 36.10 30.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.75 54.09
Gross Margin - 5 Yr. Avg. -- 52.16 52.20
EBITD Margin (TTM) -1,630.62 -- --
EBITD - 5 Yr. Avg -2,342.78 18.42 15.86
Operating Margin (TTM) -3,164.27 12.77 3.97
Operating Margin - 5 Yr. Avg. -2,677.67 14.17 11.17
Pre-Tax Margin (TTM) -2,136.33 13.01 4.62
Pre-Tax Margin - 5 Yr. Avg. -2,516.90 14.52 11.49
Net Profit Margin (TTM) -4,310.70 9.42 1.24
Net Profit Margin - 5 Yr. Avg. -2,940.10 10.85 7.83
Effective Tax Rate (TTM) -- 22.47 31.24
Effective Tax Rate - 5 Yr. Avg. -- 23.66 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) 48,703 912,108,786 806,826,037
Net Income/Employee (TTM) -2,099,423 107,196,444 94,789,739
Receivable Turnover (TTM) 13.59 5.59 5.54
Inventory Turnover (TTM) -- 2.55 3.44
Asset Turnover (TTM) 0.03 0.91 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -138.80 10.90 10.47
Return on Assets - 5 Yr. Avg. -109.58 12.09 11.49
Return on Investment (TTM) -210.44 13.53 13.13
Return on Investment - 5 Yr. Avg. -138.10 15.63 14.88
Return on Equity (TTM) -- 15.22 14.96
Return on Equity - 5 Yr. Avg. -- 16.82 16.18
  1 Year 3 Year 5 Year
Sales % 100.89 -1.28 -23.05
EPS (TTM) % 18.11 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Argos Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.56%
# of Holders: 33
Total Shares Held: 288,262
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.